Lindbrook Capital’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $885 | Sell |
26
-26
| -50% | -$885 | ﹤0.01% | 2499 |
|
|
2024
Q4 | $2.05K | Buy |
52
+2
| +4% | +$79 | ﹤0.01% | 2301 |
|
|
2024
Q3 | $2.35K | Buy |
50
+18
| +56% | +$846 | ﹤0.01% | 2292 |
|
|
2024
Q2 | $1.73K | Hold |
32
| – | – | ﹤0.01% | 2387 |
|
|
2024
Q1 | $2.18K | Hold |
32
| – | – | ﹤0.01% | 2215 |
|
|
2023
Q4 | $2K | Buy |
32
+27
| +540% | +$1.69K | ﹤0.01% | 2260 |
|
|
2023
Q3 | $227 | Sell |
5
-9
| -64% | -$409 | ﹤0.01% | 2623 |
|
|
2023
Q2 | $786 | Sell |
14
-23
| -62% | -$1.29K | ﹤0.01% | 2416 |
|
|
2023
Q1 | $1.67K | Buy |
37
+4
| +12% | +$181 | ﹤0.01% | 2319 |
|
|
2022
Q4 | $1.34K | Buy |
33
+16
| +94% | +$650 | ﹤0.01% | 2391 |
|
|
2022
Q3 | $1K | Sell |
17
-20
| -54% | -$1.18K | ﹤0.01% | 2280 |
|
|
2022
Q2 | $2K | Sell |
37
-18
| -33% | -$973 | ﹤0.01% | 1932 |
|
|
2022
Q1 | $3K | Buy |
55
+35
| +175% | +$1.91K | ﹤0.01% | 1802 |
|
|
2021
Q4 | $2K | Buy |
+20
| New | +$2K | ﹤0.01% | 1756 |
|
|
2021
Q2 | – | Sell |
-29
| Closed | -$4K | – | 1922 |
|
|
2021
Q1 | $4K | Sell |
29
-21
| -42% | -$2.9K | ﹤0.01% | 1309 |
|
|
2020
Q4 | $8K | Buy |
50
+40
| +400% | +$6.4K | ﹤0.01% | 982 |
|
|
2020
Q3 | $1K | Buy |
+10
| New | +$1K | ﹤0.01% | 1527 |
|
|
2019
Q4 | – | Sell |
-55
| Closed | -$2K | – | 1509 |
|
|
2019
Q3 | $2K | Hold |
55
| – | – | ﹤0.01% | 1245 |
|
|
2019
Q2 | $2K | Hold |
55
| – | – | ﹤0.01% | 1212 |
|
|
2019
Q1 | $1K | Hold |
55
| – | – | ﹤0.01% | 1285 |
|
|
2018
Q4 | $1K | Buy |
+55
| New | +$1K | ﹤0.01% | 1237 |
|